EXPRO GROUP HOLDINGS N.V. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that EXPRO GROUP HOLDINGS N.V. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $522.49M | Feb 25, 2019 |
| FY2017 | Dec 31, 2017 | $118.32M | Feb 27, 2018 |
| FY2017 | Sep 30, 2017 | $108.08M | Feb 27, 2018 |
| FY2017 | Jun 30, 2017 | $117.66M | Feb 27, 2018 |
| FY2017 | Mar 31, 2017 | $110.73M | Feb 27, 2018 |
| FY2017 | Dec 31, 2016 | $107.99M | Feb 27, 2018 |
| FY2017 | Sep 30, 2016 | $105.11M | Feb 27, 2018 |
| FY2017 | Jun 30, 2016 | $120.95M | Feb 27, 2018 |
| FY2017 | Mar 31, 2016 | $153.49M | Feb 27, 2018 |
| FY2016 | Dec 31, 2015 | $202.98M | Feb 24, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.61B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.71B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.51B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.28B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $825.76M | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | $96.35M | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | $84.42M | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | $86.10M | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | $123.49M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $139.44M | Mar 1, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $1.25M | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | ($616.0K) | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | $809.0K | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | $12.62M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $16.36M | Mar 1, 2021 |
| FY2020 | Sep 30, 2019 | $20.83M | Mar 1, 2021 |
| FY2020 | Jun 30, 2019 | $25.06M | Mar 1, 2021 |
| FY2020 | Mar 31, 2019 | $19.10M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $17.17M | Feb 25, 2020 |
| FY2019 | Sep 30, 2018 | $12.59M | Feb 25, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.69M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $51.92M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | ($23.36M) | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | ($20.15M) | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | ($131.89M) | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | ($8.21M) | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | ($27.79M) | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | ($34.25M) | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | ($85.98M) | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | ($168.09M) | Mar 1, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $81.14M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $94.17M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $10.80M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $2.46M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | ($127.57M) | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | ($17.65M) | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | ($23.75M) | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | ($27.29M) | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | ($94.21M) | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | ($165.28M) | Mar 1, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.40M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $17.20M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $11.40M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $7.30M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $6.70M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $10.40M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $14.40M | Mar 8, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $210.17M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $169.48M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $138.31M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $80.17M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $16.14M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $70.39M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $81.21M | Mar 8, 2022 |
| FY2020 | Dec 31, 2018 | ($32.64M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $24.77M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | ($10.83M) | Feb 25, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $112.39M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $143.58M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $122.11M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $81.90M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $81.51M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $112.39M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $104.06M | Mar 8, 2022 |
| FY2017 | Dec 31, 2017 | $21.91M | Feb 27, 2018 |
| FY2017 | Dec 31, 2016 | $42.13M | Feb 27, 2018 |
| FY2017 | Dec 31, 2015 | $99.72M | Feb 27, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.26B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.33B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $2.01B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.94B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $1.85B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.04B | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | $994.17M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.19B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $1.26B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $1.59B | Feb 27, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $725.31M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $842.06M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $717.13M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $651.26M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $557.07M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $427.77M | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | $183.87M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $159.16M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $145.87M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $276.74M | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.53B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.49B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.30B | Feb 19, 2026 |
| FY2025 | Dec 31, 2022 | $1.29B | Feb 19, 2026 |
| FY2024 | Dec 31, 2021 | $1.30B | Feb 25, 2025 |
| FY2023 | Dec 31, 2020 | $611.98M | Feb 21, 2024 |
| FY2022 | Dec 31, 2019 | $924.55M | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $992.83M | Mar 8, 2022 |
| FY2020 | Dec 31, 2017 | $1.12B | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $1.31B | Feb 25, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $348.56M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $348.92M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $247.69M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $220.98M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $179.90M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $25.50M | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | $99.93M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $211.04M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $211.04M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $211.06M | Feb 27, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($475.53M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($527.22M) | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | ($579.13M) | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | ($555.77M) | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | ($535.63M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | ($403.74M) | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | ($220.81M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $16.86M | Feb 25, 2020 |
| FY2018 | Jan 1, 2018 | $107.59M | Feb 25, 2019 |
| FY2018 | Dec 31, 2017 | $106.92M | Feb 25, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $196.09M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $183.04M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $151.74M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $214.79M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $235.39M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $116.92M | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | $195.38M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $186.21M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $213.02M | Feb 25, 2019 |
| FY2018 | Dec 31, 2016 | $319.53M | Feb 25, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $79.07M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $121.07M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $20.00M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $0 | Feb 21, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | (1) | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | (4) | Feb 23, 2023 |
| FY2017 | Dec 31, 2017 | 0 | Feb 27, 2018 |
| FY2016 | Dec 31, 2016 | 0 | Feb 24, 2017 |
| FY2016 | Sep 30, 2016 | 0 | Feb 24, 2017 |
| FY2016 | Jun 30, 2016 | 0 | Feb 24, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 25, 2025 |
| FY2017 | Dec 31, 2017 | 0 | Feb 27, 2018 |
| FY2016 | Dec 31, 2016 | 0 | Feb 24, 2017 |
| FY2016 | Sep 30, 2016 | 0 | Feb 24, 2017 |
| FY2016 | Jun 30, 2016 | 0 | Feb 24, 2017 |
| FY2016 | Mar 31, 2016 | 0 | Feb 24, 2017 |
| FY2016 | Dec 31, 2015 | 0 | Feb 24, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 116.30M | Feb 25, 2025 |
| FY2024 | Dec 31, 2023 | 110.03M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | 108.74M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | 109.14M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 70.89M | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | 225.51M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 224.29M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | 223.29M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | 222.40M | Feb 27, 2018 |
| FY2016 | Dec 31, 2015 | 155.15M | Feb 24, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $0 | Feb 25, 2020 |
| FY2019 | Dec 31, 2018 | $0 | Feb 25, 2020 |
| FY2019 | Dec 31, 2017 | $50.15M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $79.01M | Feb 25, 2019 |
| FY2017 | Dec 31, 2015 | $92.84M | Feb 27, 2018 |
| FY2016 | Dec 31, 2014 | $69.31M | Feb 24, 2017 |
| FY2015 | Dec 31, 2013 | $11.51M | Feb 29, 2016 |
| FY2014 | Dec 31, 2012 | $0 | Mar 6, 2015 |
| FY2013 | Dec 31, 2011 | $0 | Mar 4, 2014 |